| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2001 |
Byrne J, Glover L, Alleng G, Inniss V, Mun Y, Wang Y. The Postmodern Greenhouse: Creating Virtual Carbon Reductions From Business-as-Usual Energy Politics Bulletin of Science, Technology & Society. 21: 443-455. DOI: 10.1177/027046760102100603 |
0.265 |
|
| 2014 |
Lee HS, Kim YS, Min C, Lee J, Kim K, Yoon DH, Eom HS, Lee H, Lee WS, Shin H, Lee JH, Park Y, Jo J, Do YR, Mun Y. The Clinical Impact of Thalidomide Maintenance on Progression Free Survival and Postrelapse Survival after Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple myeloma Blood. 124: 3975-3975. DOI: 10.1182/blood.v124.21.3975.3975 |
0.252 |
|
| 2011 |
Kim D, Joo YD, Lee J, Lee J, Kim DH, Jung CW, Kim I, Yoon S, Yang D, Lee J, Kim YS, Mun Y, Kim H, Sohn SK, Lee WS, et al. Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study Blood. 118: 1517-1517. DOI: 10.1182/blood.v118.21.1517.1517 |
0.249 |
|
| 2011 |
Kim MK, Min C, Hyun MS, Kim K, Yoon S, Kim JS, Eom HS, Suh C, Kang HJ, Kim J, Mun Y, Shin H, Jo D, Choi CW, Moon JH, et al. Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers Blood. 118: 1866-1866. DOI: 10.1182/blood.v118.21.1866.1866 |
0.248 |
|
| 2017 |
Jung SH, Lee JJ, Kim K, Suh C, Yoon DH, Min CK, Sohn SK, Choi CW, Lee HS, Kim HJ, Shin HJ, Bang SM, Yoon SS, Park SK, Yhim HY, ... ... Mun YC, et al. The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160). Oncotarget. PMID 28634317 DOI: 10.18632/oncotarget.18535 |
0.239 |
|
| 2014 |
Lee HS, Kim K, Yoon DH, Kim JS, Bang SM, Lee JO, Eom HS, Lee H, Kim I, Lee WS, Bae SH, Kim SH, Lee MH, Do YR, Lee JH, ... ... Mun YC, et al. Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea. Biomed Research International. 2014: 253243. PMID 24995279 DOI: 10.1155/2014/253243 |
0.238 |
|
| 2015 |
Ahn JS, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, ... Mun YC, et al. Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome. Acta Haematologica. 134: 40-8. PMID 26066466 DOI: 10.1159/000368711 |
0.237 |
|
| 2015 |
Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y, Jo JC, Kim SJ, Yoon DH, Cheong JW, Kwak JY, Lee JJ, Kim WS, Suh C, Yang DH, et al. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 25963920 DOI: 10.1016/j.bbmt.2015.05.003 |
0.235 |
|
| 2014 |
Kim K, Kim SJ, Voelter V, Suh C, Yoon SS, Lee JJ, Kwak JY, Ryoo HM, Kim YS, Moon JH, Park SK, Kim SH, Mun YC, Kim JS, Eom HS, et al. Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients. Annals of Hematology. 93: 113-21. PMID 24026427 DOI: 10.1007/s00277-013-1893-z |
0.233 |
|
| 2015 |
Jeong SH, Kim YJ, Lee JH, Kim YK, Kim SJ, Park SK, Do YR, Kim I, Mun YC, Kim HG, Lee WS, Yi HG, Joo YD, Choi CW, Kim SR, et al. A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome. Oncotarget. PMID 26517692 DOI: 10.18632/oncotarget.6242 |
0.23 |
|
| 2016 |
Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, et al. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget. PMID 27713132 DOI: 10.18632/oncotarget.12459 |
0.23 |
|
| 2009 |
Kim SJ, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, et al. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry. Acta Haematologica. 122: 200-10. PMID 19887776 DOI: 10.1159/000253027 |
0.229 |
|
| 2016 |
Kim MK, Kim K, Yoon DH, Suh C, Lee JH, Jung S, Lee J, Kim HJ, Kim JS, Lee J, Eom HS, Lee WS, Mun Y, Do YR, Kang HJ. Bortezomib-Melphalan-Prednisone (VMP) Versus MP As Initial Treatment for Patients Older Than 75 Years with Newly Diagnosed Multiple Myeloma Blood. 128: 5683-5683. DOI: 10.1182/blood.V128.22.5683.5683 |
0.227 |
|
| 2015 |
Hong J, Kim SJ, Ahn JS, Song MK, Kim YR, Lee HS, Yhim HY, Yoon DH, Kim MK, Oh SY, Park Y, Mun YC, Do YR, Ryoo HM, Lee JJ, et al. Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 47: 173-81. PMID 25544581 DOI: 10.4143/crt.2014.055 |
0.224 |
|
| 2013 |
Lee YG, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Park J, et al. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes. British Journal of Haematology. 161: 339-47. PMID 23432512 DOI: 10.1111/bjh.12256 |
0.223 |
|
| 2008 |
Mun Y, Lee JH, Kim BK, Park S, Yoon S, Bang S, Moon HN, Jo D, Kim CS, Oh D, Park JH, Joo Y, Zang DY, Kim I, Cho EK, et al. Final Report of “Korean Multicenter AML-2000 Trial”: Intention to Treat Analysis Based on Cytogenetics Risk Blood. 112: 2975-2975. DOI: 10.1182/blood.v112.11.2975.2975 |
0.222 |
|
| 2020 |
Yoon SE, Kim SJ, Yoon DH, Koh Y, Mun YC, Do YR, Choi YS, Yang DH, Kim MK, Lee GW, Suh C, Ko YH, Kim WS. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis. Annals of Hematology. PMID 32333154 DOI: 10.1007/s00277-020-04005-6 |
0.221 |
|
| 2011 |
Lee HS, Kim YS, Kim K, Kim JS, Kim HJ, Min C, Suh C, Eom H, Yoon S, Lee JH, Kim MK, Kim SH, Bae SH, Mun Y, Jo DY, et al. Early Response to Botezomib Combined Chemotherapy Can Be Helpful for Prediction of Progression Free Survival in Patients with Multiple Myeloma Who Were Ineligible for Stem Cell Transplantation Blood. 118: 5138-5138. DOI: 10.1182/blood.v118.21.5138.5138 |
0.221 |
|
| 2016 |
Lee HS, Min CK, Lee JJ, Kim K, Kim SJ, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC, et al. The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea. Annals of Hematology. PMID 27052989 DOI: 10.1007/s00277-016-2660-8 |
0.22 |
|
| 2013 |
Yhim HY, Kim K, Kim JS, Kang HJ, Kim JA, Min CK, Bae SH, Park E, Yang DH, Suh C, Kim MK, Mun YC, Eom HS, Shin HJ, Yoon HJ, et al. Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT. Bone Marrow Transplantation. 48: 425-32. PMID 22941384 DOI: 10.1038/bmt.2012.164 |
0.219 |
|
| 2014 |
Jeong SH, Kim DY, Jang JH, Mun Y, Kim S, Choi CW, Kim JS, Park JS. a Randomized, Controlled, Prospective Study for Efficacy of Micafungin Versus Itraconazole As Empirical Antifungal Therapy for Febrile Neutropenic Patients with Acute Leukemia Blood. 124: 3729-3729. DOI: 10.1182/blood.v124.21.3729.3729 |
0.218 |
|
| 2013 |
Lee SE, Choi SY, Bang JH, Kim SH, Jang EJ, Byeun JY, Park JE, Jeon HR, Oh YJ, Kim HJ, Kim YK, Park JS, Jeong SH, Kim SH, Zang DY, ... ... Mun YC, et al. Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib. American Journal of Hematology. 88: 449-54. PMID 23440689 DOI: 10.1002/ajh.23427 |
0.218 |
|
| 2009 |
Kim SJ, Oh S, Choi CW, Lee SI, Kim HS, Oh SY, Won JH, Kim JS, Kim MK, Kang HJ, Mun Y, Kwak J, Kwon JM, Park J, Kim HJ, et al. Treatment Outcome and Quality of Life in Non-Hodgkin's Lymphoma of Intestine: a Multicenter Study of the Consortium for Improving Survival of Lymphoma (CISL). Blood. 114: 4992-4992. DOI: 10.1182/blood.V114.22.4992.4992 |
0.217 |
|
| 2008 |
Koh Y, Bang S, Lee JH, Yoon H, Do Y, Ryoo H, Lee N, Kim SJ, Yoon S, Won J, Mun Y, Lee M, Jin J, Kim H, Eom H, et al. Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population? Blood. 112: 5146-5146. DOI: 10.1182/blood.v112.11.5146.5146 |
0.216 |
|
| 2009 |
Kim KH, Won J, Park H, Jeong SH, Lee HW, Park JS, Cho S, Lee JM, Park CW, Kim DH(, Jang JH, Lee WS, Lee JL, Mun Y, Seong C, et al. Multicenter Retrospective Analysis of High Dose Chemotherapy and Autologous PBSCT for Ovarian Cancer. Blood. 114: 4365-4365. DOI: 10.1182/blood.v114.22.4365.4365 |
0.216 |
|
| 2017 |
Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, et al. Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma. Oncotarget. 8: 92171-92182. PMID 29190906 DOI: 10.18632/oncotarget.20988 |
0.215 |
|
| 2013 |
Yang D, Kim WS, Do Y, Oh SY, Kim MK, Mun Y, Shin H, Kwak J, Kang HJ, Won J, Kwon Jh, Kim HJ, Suh C, Lee J. Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma Blood. 122: 3031-3031. DOI: 10.1182/blood.V122.21.3031.3031 |
0.214 |
|
| 2013 |
Lee HS, Kim YS, Kim K, Kim JS, Kim HJ, Min CK, Suh C, Eom HS, Yoon SS, Lee JH, Kim MK, Kim SH, Bae SH, Mun YC, Jo DY, et al. Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation. Journal of Korean Medical Science. 28: 80-6. PMID 23341716 DOI: 10.3346/jkms.2013.28.1.80 |
0.213 |
|
| 2016 |
Kim KH, Jae Hoon L, Lee M, Hoon-Gu K, Do YR, Park Y, Oh SY, Shin H, Kim WS, Park S, Won J, Kong JH, Park M, Lee J, Kwak J, ... ... Mun Y, et al. Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL) Blood. 128: 3466-3466. DOI: 10.1182/blood.V128.22.3466.3466 |
0.212 |
|
| 2010 |
Kim DY, Lee JH, Lee JH, Lee KH, Kim YK, Ahn JS, Kim HJ, Kim I, Yoon SS, Park S, Bae SH, Bang SM, Lee HG, Shin HJ, Lee JH, ... ... Mun YC, et al. Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine. Annals of Hematology. 89: 15-23. PMID 19543727 DOI: 10.1007/s00277-009-0771-1 |
0.21 |
|
| 2008 |
Kim SJ, Kim K, Lee JH, Kim MK, Kwak J, Ryoo H, Suh C, Yoon S, Lee M, Mun Y, Lee H, Min C, Kim JS, Yoon H. Bortezomib-Based Induction Therapy Induces Better Responses and Outcomes of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: The Results of Korean Multiple Myeloma Working Party Retrospective Study, KMM84 Blood. 112: 5184-5184. DOI: 10.1182/BLOOD.V112.11.5184.5184 |
0.21 |
|
| 2015 |
Jung SH, Lee JJ, Kim WS, Lee WS, Do YR, Oh SY, Kim MK, Mun YC, Shin HJ, Kwak JY, Kang HJ, Won JH, Kwon JH, Park E, Suh C, et al. Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL). European Journal of Haematology. 94: 504-10. PMID 25288018 DOI: 10.1111/ejh.12459 |
0.208 |
|
| 2011 |
Kim H, Mun Y, Yoo E, Lee KE, Nam E, Lee SN, Seong C. Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning in the Patients with Acute Leukemia Blood. 118: 4508-4508. DOI: 10.1182/blood.v118.21.4508.4508 |
0.205 |
|
| 2014 |
Eom KS, Kim SJ, Lee JJ, Suh C, Kim JS, Yoon SS, Kim BS, Kang HJ, Choi YJ, Kim CS, Kim YS, Kwak JY, Kim YJ, Joo YD, Mun YC, et al. Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter study. Biomed Research International. 2014: 245247. PMID 25050331 DOI: 10.1155/2014/245247 |
0.203 |
|
| 2010 |
Kim JS, Kim WS, Kim SJ, Eom HS, Yang D, Kim YS, Kim HJ, Kim MK, Oh S, Yoon S, Ryoo H, Kwak J, Lee JH, Choi CW, Kang HJ, ... Mun Y, et al. Intensified 1st Cycle Rituximab (R) Plus 8th Cycles of R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) Chemotherapy In Patients with Advanced or Bulky CD20+ Diffuse Large B-Cell Lymphoma (DLBCL); Open-Labelled, Multicenter Phase II CISL Study-Interim Analysis. Blood. 116: 1786-1786. DOI: 10.1182/blood.v116.21.1786.1786 |
0.202 |
|
| 2012 |
Kim SJ, Park Y, Lee SI, Eom HS, Kim JS, Kim MK, Do YR, Yoon DH, Won J, Mun Y, Lee WS, Kang HJ, Kim HJ, Kwon JH, Kim J, et al. Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement. Blood. 120: 2683-2683. DOI: 10.1182/BLOOD.V120.21.2683.2683 |
0.199 |
|
| 2017 |
Cho H, Yoon DH, Lee JB, Kim SY, Moon JH, Do YR, Lee JH, Park Y, Lee HS, Eom HS, Shin HJ, Min CK, Kim JS, Jo JC, Kang HJ, ... Mun YC, et al. Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy. American Journal of Hematology. PMID 28833417 DOI: 10.1002/ajh.24891 |
0.197 |
|
| 2007 |
Yang D, Kim WS, Kim SJ, Bae SH, Kim SH, Kim IH, Mun Y, Shin H, Chae YS, Kwak J, Kim H, Kim MK, Kim JS, Baek JH, Suh CW, et al. The Clinical Outcomes of Autologous Stem Cell Transplantation in Peripheral T Cell Lymphoma: from Retrospective Multicenter Study in Korea. Blood. 110: 1892-1892. DOI: 10.1182/BLOOD.V110.11.1892.1892 |
0.197 |
|
| 2015 |
Kim C, Lee HS, Min CK, Lee JJ, Kim K, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC. The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea. The Korean Journal of Internal Medicine. 30: 675-83. PMID 26354062 DOI: 10.3904/kjim.2015.30.5.675 |
0.197 |
|
| 2014 |
Oh S, Koo DH, Kwon MJ, Kim K, Suh C, Min CK, Yoon SS, Shin HJ, Jo DY, Kwak JY, Kim JS, Sohn SK, Joo YD, Eom HS, Kim SH, ... ... Mun YC, et al. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study. Annals of Hematology. 93: 1353-61. PMID 24671365 DOI: 10.1007/s00277-014-2057-5 |
0.196 |
|
| 2015 |
Lee S, Choi SY, Kwak J, Kim H, Kim J, Do YR, Kim HJ, Park JS, Chung JS, Shin H, Kim S, Kim D, Bunworasate U, Choi CW, Comia NSC, ... ... Mun Y, et al. Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib Blood. 126: 4053-4053. DOI: 10.1182/blood.V126.23.4053.4053 |
0.191 |
|
| 2015 |
Jeong SH, Kim DY, Jang JH, Mun YC, Choi CW, Kim SH, Kim JS, Park JS. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study. Annals of Hematology. PMID 26596974 DOI: 10.1007/s00277-015-2545-2 |
0.189 |
|
| 2011 |
Yhim H, Kim K, Kim JS, Kang HJ, Kim J, Min C, Bae SH, Park E, Yang D, Suh C, Kim MK, Mun Y, Eom HS, Shin HJ, Yoon H, et al. Matched-Pair Analysis Comparing Outcomes of Second Autologous Stem Cell Transplantation and Chemotherapy As a Salvage Therapy in Patients with Multiple Myeloma Who Relapsed After Front-Line Autologous Stem Cell Transplantation Blood. 118: 1990-1990. DOI: 10.1182/blood.v118.21.1990.1990 |
0.188 |
|
| 2016 |
Suh KJ, Cheong JW, Kim I, Kim HJ, Shin DY, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, et al. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome. Plos One. 11: e0166245. PMID 27824923 DOI: 10.1371/journal.pone.0166245 |
0.188 |
|
| 2014 |
Kim C, Lee HS, Kim YS, Min C, Lee J, Kim K, Yoon DH, Eom HS, Lee H, Lee WS, Shin H, Lee JH, Park Y, Jo J, Do YR, ... Mun Y, et al. The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation Blood. 124: 5896-5896. DOI: 10.1182/blood.v124.21.5896.5896 |
0.188 |
|
| 2019 |
Jung KS, Kim YJ, Kim YK, Park SK, Kim HG, Kim SJ, Park J, Choi CW, Do YR, Kim I, Park S, Mun YC, Jeong SH, Kim MK, Yi HG, et al. Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System. Clinical Lymphoma, Myeloma & Leukemia. PMID 31375393 DOI: 10.1016/j.clml.2019.06.003 |
0.187 |
|
| 2011 |
Kim SJ, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, Won JH, Kim MK, Kwon JH, Kim JS, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Lee JH, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). Bmc Cancer. 11: 321. PMID 21798075 DOI: 10.1186/1471-2407-11-321 |
0.186 |
|
| 2015 |
Kim JW, Min CK, Mun YC, Park Y, Kim BS, Nam SH, Koh Y, Kwon JH, Choe PG, Park WB, Kim I. Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 73: 64-69. PMID 26546878 DOI: 10.1016/j.jcv.2015.10.018 |
0.183 |
|
| 2016 |
Lee SE, Choi SY, Song HY, Kim SH, Choi MY, Park JS, Kim HJ, Kim SH, Zang DY, Oh S, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, ... Mun YC, et al. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study. Haematologica. PMID 26888022 DOI: 10.3324/haematol.2015.139899 |
0.182 |
|
| 2009 |
Lee K, Woo HA, Yang SH, Huh J, Ahn J, Oh SA, Mun Y, Yoo E, Nam E, Rhee SG, Seong C. The Level of Peroxiredoxin and Catalase On Single Cell Level Is Correlated with the Positivity of Ph Chromosome in the Bone Marrow of CML Patients During Imatinib Therapy. Blood. 114: 1114-1114. DOI: 10.1182/blood.V114.22.1114.1114 |
0.179 |
|
| 2013 |
Yi JH, Huh J, Kim HJ, Kim SH, Kim SH, Kim KH, Do YR, Mun YC, Kim H, Kim MK, Kim HJ, Kim T, Kim DD. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment. Annals of Hematology. 92: 459-69. PMID 23262795 DOI: 10.1007/s00277-012-1635-7 |
0.176 |
|
| 2015 |
Kim DY, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, ... ... Mun YC, et al. Nilotinib combined with multi-agent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia. Blood. PMID 26065651 DOI: 10.1182/blood-2015-03-636548 |
0.175 |
|
| 2014 |
Park JH, Yoon DH, Kim S, Park JS, Lee S, Park C, Huh J, Kim SJ, Chang MH, Eom HS, Park Y, Kim JS, Lee SI, Kim MK, Do YR, ... ... Mun Y, et al. Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma Blood. 124: 4421-4421. DOI: 10.1182/blood.V124.21.4421.4421 |
0.172 |
|
| 2012 |
Huh J, Kim HJ, Jung CW, Kim HJ, Kim SH, Kim YK, Kim HJ, Shin MG, Moon JH, Sohn SK, Kim SH, Lee WS, Won JH, Mun YC, Kim H, et al. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia. American Journal of Hematology. 87: 961-8. PMID 22886749 DOI: 10.1002/ajh.23281 |
0.17 |
|
| 2017 |
Choi JH, Kim TM, Kim HJ, Koh SA, Mun YC, Kang HJ, Jung YH, Shim H, Chong SY, Sun DS, Lee S, Park BB, Kwon JH, Nam SH, Yi JH, et al. Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns and Outcomes in Very Elderly Patients with Diffuse Large B-cell Lymphoma: The Korean Cancer Study Group LY16-01. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28602052 DOI: 10.4143/crt.2017.172 |
0.17 |
|
| 2014 |
Kim JS, Cheong JW, Kim YK, Park J, Mun YC, Kang HJ, Yi HG, Lee JH, Kim YS, Ryoo HM, Kim SH, Kim HY, Kim JY, Lee DG, Kim HG, et al. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea. Annals of Hematology. 93: 33-42. PMID 23807252 DOI: 10.1007/s00277-013-1826-x |
0.169 |
|
| 2017 |
Jo J, Lee HS, Min CK, Kim K, Lee J, Bang S, Kim JS, Eom H, Lee JH, Yoon DH, Kim I, Shin H, Park Y, Lee WS, Do YR, ... Mun Y, et al. Clinical Features and Results of Bortezomib-Melphalan-Prednisone (VMP) as Initial Treatment in Elderly Multiple Myeloma Patients Received Lenalidomide with Dexamethasone (Len/Dex): Subgroup Analysis of Lenalidomide Registry from Korean Multiple Myeloma Working Party (KMM151) Clinical Lymphoma Myeloma and Leukemia. 17: e129. DOI: 10.1016/j.clml.2017.03.233 |
0.168 |
|
| 2013 |
Lee SM, Lee WS, Shin HJ, Lee JJ, Sohn SK, Moon JH, Eom HS, Won JH, Lee KH, Lee JH, Kim DY, Yoon SS, Kim I, Jung CW, Kim SJ, ... ... Mun YC, et al. Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia. Annals of Hematology. 92: 1101-10. PMID 23558905 DOI: 10.1007/s00277-013-1728-y |
0.167 |
|
| 2012 |
Kim S, Kim HJ, Kwak J, Kim JS, Mun Y, Park JS, Sohn SK, Kim D. Hepatitis B Virus Reactivation in Chronic Myeloid Leukemia Treated with Various Tyrosine Kinase Inhibitors: Multicenter, Retrospective Study Blood. 120: 3738-3738. DOI: 10.1182/BLOOD.V120.21.3738.3738 |
0.167 |
|
| 2015 |
Park S, Huh HJ, Mun YC, Seong CM, Chung WS, Chung HS, Huh J. Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia. Cancer Genetics. PMID 26640226 DOI: 10.1016/j.cancergen.2015.11.001 |
0.166 |
|
| 2013 |
Kim Y, Lee SR, Park Y, Choi CW, Kim SJ, Yhim H, Kim I, Oh D, Mun Y, Lim S, Kim J, Shin M, Won J. Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment Blood. 122: 1596-1596. DOI: 10.1182/BLOOD.V122.21.1596.1596 |
0.165 |
|
| 2007 |
Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH, Chung IJ, Seong CM, Kim HJ. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation. American Journal of Hematology. 82: 1-5. PMID 16986129 DOI: 10.1002/ajh.20739 |
0.16 |
|
| 2005 |
Yang D, Mun Y, Shin H, Kim Y, Lee J, Jin C, Seong C, Kim H. Predictable Prognostic Factor of CD56 Expression in Acute Myeloid Leukemia with t(8:21) Including Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 106: 3288-3288. DOI: 10.1182/blood.V106.11.3288.3288 |
0.16 |
|
| 2014 |
Park S, Huh HJ, Mun YC, Seong C, Chung WS, Huh J. Calreticulin mRNA Expression Levels and Clinicopathologic Characteristics in Hematologic Malignancies Blood. 124: 5184-5184. DOI: 10.1182/blood.V124.21.5184.5184 |
0.16 |
|
| 2015 |
Kwak J, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Chung JS, Shin H, Kim S, Kim D, Bunworasate U, Choi CW, Comia NSC, Zang DY, Oh S, ... ... Mun Y, et al. Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial Blood. 126: 476-476. DOI: 10.1182/blood.V126.23.476.476 |
0.157 |
|
| 2013 |
Yoo E, Mun Y, Ahn J, Huh J, Lee KE, Nam E, Lee S, Seong C. Up Regulation Of Peroxiredoxin 2 Which Is Correlated With Disappearance Of Philadelphia Chromosome In CML Cells Might Have Therapeutic Applications During Imatinib Therapy Blood. 122: 5164-5164. DOI: 10.1182/blood.V122.21.5164.5164 |
0.156 |
|
| 2012 |
Kim YR, Kim JS, Min YH, Hyunyoon D, Shin HJ, Mun YC, Park Y, Do YR, Jeong SH, Park JS, Oh SY, Lee S, Park EK, Jang JS, Lee WS, et al. Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). Journal of Hematology & Oncology. 5: 49. PMID 22889180 DOI: 10.1186/1756-8722-5-49 |
0.153 |
|
| 2014 |
Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, Mun Y, Sloan JA, Kaufman PA. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. Breast (Edinburgh, Scotland). 23: 763-9. PMID 25193423 DOI: 10.1016/j.breast.2014.08.004 |
0.149 |
|
| 2013 |
Hahm C, Mun YC, Seong CM, Han SH, Chung WS, Huh J. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality. Acta Haematologica. 129: 154-8. PMID 23208021 DOI: 10.1159/000343420 |
0.148 |
|
| 2014 |
Kim SJ, Cheong JW, Min YH, Choi YJ, Lee DG, Lee JH, Yang DH, Lee SM, Kim SH, Kim YS, Kwak JY, Park J, Kim JY, Kim HG, Kim BS, ... ... Mun YC, et al. Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea. Journal of Korean Medical Science. 29: 61-8. PMID 24431907 DOI: 10.3346/jkms.2014.29.1.61 |
0.146 |
|
| 2012 |
Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A. Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study. The Oncologist. 17: 1486-95. PMID 23015662 DOI: 10.1634/theoncologist.2012-0190 |
0.145 |
|
| 2007 |
Lee K, Woo H, Yang S, Huh J, Choi MY, Chang HJ, Ahn J, Oh SA, Mun Y, Yoo E, Rhee SG, Seong C. Restoration of Peroxiredoxins and Catalase Is Closely Correlated with the Level of Philadelphia Chromosome during Imatinib Therapy in CML. Blood. 110: 4539-4539. DOI: 10.1182/blood.v110.11.4539.4539 |
0.144 |
|
| 2011 |
Huh J, Kim H, Min W, Jung CW, Kim H, Kim S, Kim Y, Kim HJ, Moon JH, Sohn SK, Kim SH, Lee WS, Won J, Mun Y, Kim H, et al. Genome-Wide Single-Nucleotide Polymorphism-Array Can Improve Prognostic Stratification of Core Binding Factor Acute Myeloid Leukemia, Especially in the Subgroup with Inv(16)/t(16;16) or without D816 C-KIT Mutation, Blood. 118: 3515-3515. DOI: 10.1182/BLOOD.V118.21.3515.3515 |
0.143 |
|
| 2015 |
Park JS, Lee SE, Jeong SH, Jang EJ, Choi MY, Kim HJ, Kim YK, Kim SH, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak JY, Kim JA, ... ... Mun YC, et al. Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients. Leukemia & Lymphoma. 1-7. PMID 25947037 DOI: 10.3109/10428194.2015.1049166 |
0.143 |
|
| 2017 |
Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, et al. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29077846 DOI: 10.1093/annonc/mdx684 |
0.141 |
|
| 2009 |
Cho IJ, Chang HJ, Lee KE, Won HS, Choi MY, Nam EM, Mun YC, Lee SN, Seong CM. A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy. Journal of Korean Medical Science. 24: 747-50. PMID 19654964 DOI: 10.3346/jkms.2009.24.4.747 |
0.14 |
|
| 2012 |
Kong JH, Mun YC, Kim S, Choi HS, Kim YK, Kim HJ, Moon JH, Sohn SK, Kim SH, Jung CW, Dennis Kim DH. Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia. International Journal of Hematology. 96: 327-33. PMID 22821389 DOI: 10.1007/s12185-012-1142-6 |
0.138 |
|
| 2017 |
Lee HS, Min CK, Kim K, Lee J, Bang S, Kim JS, Eom HS, Lee JH, Yoon DH, Kim I, Shin H, Park Y, Jo J, Lee WS, Mun Y, et al. The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP) Clinical Lymphoma Myeloma and Leukemia. 17: e74-e75. DOI: 10.1016/j.clml.2017.03.135 |
0.134 |
|
| 2019 |
Kim JS, Cheong JW, Mun YC, Jang JH, Jo DY, Lee JW. Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis. Annals of Hematology. PMID 31256219 DOI: 10.1007/s00277-019-03735-6 |
0.132 |
|
| 2018 |
Yhim HY, Choi WI, Kim SH, Nam SH, Kim KH, Mun YC, Oh D, Hwang HG, Lee KW, Song EK, Kwon YS, Bang SM. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial. The Korean Journal of Internal Medicine. PMID 29788694 DOI: 10.3904/kjim.2018.097 |
0.131 |
|
| 2015 |
Hahm C, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. International Journal of Laboratory Hematology. 37: 181-9. PMID 24845343 DOI: 10.1111/ijlh.12257 |
0.13 |
|
| 2016 |
Yoo E, Mun Y, Ahn J, Huh J, Seong C. Prx II(Peroxiredoxin II) Activity Has Important Roles As a New Mechanism to Control ABL Tyrosine Kinase Activity in STIs(Signal Transduction Inhibitor) Treated CML Patients Blood. 128: 5431-5431. DOI: 10.1182/blood.v128.22.5431.5431 |
0.129 |
|
| 2013 |
Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, et al. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Annals of Hematology. 92: 163-71. PMID 23053179 DOI: 10.1007/s00277-012-1580-5 |
0.126 |
|
| 2013 |
Choi H, Jung C, Sohn SK, Kim S, Kim HJ, Kim YK, Kim T, Zhang Z, Shin ES, Lee JE, Moon JH, Kim SH, Kim KH, Mun YC, Kim H, et al. Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype. British Journal of Haematology. 163: 62-71. PMID 24159609 DOI: 10.1182/Blood.V120.21.2526.2526 |
0.123 |
|
| 2007 |
Kong JH, Yoo SH, Lee KE, Nam SH, Kwon JM, Lee SM, Chang HJ, Choi MY, Cho MS, Mun YC, Nam E, Lee SN, Seong CM. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia. Acta Haematologica. 118: 205-8. PMID 18030002 DOI: 10.1159/000111092 |
0.122 |
|
| 2017 |
Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, et al. Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28939746 DOI: 10.1158/1078-0432.CCR-17-0957 |
0.122 |
|
| 2016 |
Bang S, Mun Y, Shin H, Jung CW, Bae SH, Sohn SK, Kim KH, Kim H, Yhim H, Hong J, Kim HJ, Lee J, Oh D. Prospective, Non-Randomized, Open-Label, Single-Arm, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin 10% Formulation in Patients with Immune Thrombocytopenia (ITP) Blood. 128: 4938-4938. DOI: 10.1182/blood.V128.22.4938.4938 |
0.121 |
|
| 2014 |
Mun Y, Ahn J, Yoo E, Cho KM, Lee KE, Nam E, Lee SN, Woo HA, Rhee SG, Seong C. The Role of Peroxiredoxin III and Sulfiredoxin for Mitochondrial ROS Production to Arsenic Trioxide in Acute Promyelocytic Leukemia Cells Blood. 124: 5217-5217. DOI: 10.1182/blood.V124.21.5217.5217 |
0.121 |
|
| 2018 |
So M, Park S, Cho M, Mun YC, Huh J. Anaplastic Large Cell Lymphoma with Massive Eosinophilia and Complex Karyotype Initially Misdiagnosed as Chronic Eosinophilic Leukemia Laboratory Medicine Online. 8: 56. DOI: 10.3343/LMO.2018.8.2.56 |
0.119 |
|
| 2014 |
Hurwitz HI, Bekaii-Saab TS, Bendell JC, Cohn AL, Kozloff M, Roach N, Mun Y, Fish S, Flick ED, Grothey A. Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort study. Clinical Oncology (Royal College of Radiologists (Great Britain)). 26: 323-32. PMID 24686090 DOI: 10.1016/j.clon.2014.03.001 |
0.116 |
|
| 2018 |
Park S, Choi H, Kim HJ, Ahn JS, Kim HJ, Kim SH, Mun YC, Jung CW, Kim DDH. Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients. Annals of Hematology. PMID 29500710 DOI: 10.1007/s00277-018-3260-6 |
0.115 |
|
| 2016 |
Go SJ, Cho BS, Mun YS, Kang YJ, Ahn HY. Study on the Long-Term Results of Endovenous Laser Ablation for Treating Varicose Veins. The International Journal of Angiology : Official Publication of the International College of Angiology, Inc. 25: 117-20. PMID 27231428 DOI: 10.1055/s-0035-1555749 |
0.111 |
|
| 2014 |
Grothey A, Flick ED, Cohn AL, Bekaii-Saab TS, Bendell JC, Kozloff M, Roach N, Mun Y, Fish S, Hurwitz HI. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study. Pharmacoepidemiology and Drug Safety. 23: 726-34. PMID 24830357 DOI: 10.1002/pds.3633 |
0.111 |
|
| 2007 |
Lee JB, Mun Y, Park HS, Choi MY, Chang HJ, Lee KE, Nam EM, Lee SN, Sung C. The Results of Danazol Therapy in Patients with Chronic Immune Thrombocytopenic Purpura Who Failed with Corticosteroid Therapy The Korean Journal of Hematology. 42: 353. DOI: 10.5045/kjh.2007.42.4.353 |
0.109 |
|
| 2013 |
Gan CK, Sapar AF, Mun YC, Chong KE. Techno-economic analysis of LED lighting: A case study in UTeM's faculty building Procedia Engineering. 53: 208-216. DOI: 10.1016/j.proeng.2013.02.028 |
0.109 |
|
| 2009 |
Lee SM, Park JJ, Sung SH, Kim Y, Lee KE, Mun YC, Lee SN, Seong CM. Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation. The Korean Journal of Internal Medicine. 24: 156-9. PMID 19543497 DOI: 10.3904/kjim.2009.24.2.156 |
0.107 |
|
| 2004 |
Mun Y, Hwang E, Lee K, Kwon JM, Nam S, Yoo ES, Bae Y, Lee S, Ahn J, Hyun MS, Kwon KY, Lee SN, Seong C. Signaling Mechanisms of Anti-Proliferation by Sphingosine 1-Phoshate(S1P) on Acute Promyelocytic Leukemia(APL) Cell Lines. Blood. 104: 4468-4468. DOI: 10.1182/blood.v104.11.4468.4468 |
0.107 |
|
| 2008 |
Yoo E, Ahn J, Kwon K, Oh S, Choi M, Mun Y, Lee K, Seong C. Characterization of Angiogenic Potential of Late Endothelial Progenitor Cells on Human Cord Blood and Bone Marrow Blood. 112: 5404-5404. DOI: 10.1182/blood.v112.11.5404.5404 |
0.107 |
|
| 2016 |
Mun Y, Ahn J, Kang SH, Yoo E, Lee KE, Nam E, Lee SN, Woo HA, Rhee SG, Seong C. Bortezomib-Induced Apoptosis in Myeloma Cell Via Oxidation of Peroxiredoxin III and Thioredoxin 2 Blood. 128: 2081-2081. DOI: 10.1182/blood.v128.22.2081.2081 |
0.107 |
|
| 2006 |
Nam E, Kwon JM, Lee SN, Nam SH, Lee K, Mun Y, Seung C, Park SH, Bang S, Cho EK, Shin DB, Lee JH. Vascular Complications in Patients with Essential Thrombocythemia The Korean Journal of Hematology. 41: 149. DOI: 10.5045/kjh.2006.41.3.149 |
0.106 |
|
| 2008 |
Ha YJ, Mun YC, Seong CM, Lee JR. Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells. Journal of Leukocyte Biology. 84: 1557-64. PMID 18725396 DOI: 10.1189/jlb.0706457 |
0.106 |
|
| 2015 |
Yang N, Park S, Chung H, Mun YC, Yu S, Kwon M, Woo H, Oh S, Lee M. Therapeutic Plasma Exchange for a Patient with Severe Cold Agglutinin Disease The Korean Journal of Blood Transfusion. 26: 75-80. DOI: 10.17945/KJBT.2015.26.1.75 |
0.106 |
|
| 2007 |
Yoo E, Kwon K, Ahn J, Oh S, Chang H, Choi M, Mun Y, Lee K, Seong C. Outgrowing Endothelial Cells That Are Derived from Human Umbilical Cord Blood Improve Neovascularization in Hind-Limb Ischemia. Blood. 110: 3697-3697. DOI: 10.1182/blood.V110.11.3697.3697 |
0.105 |
|
| 2006 |
Yoo E, Ahn J, Bae Y, Kong JH, Lee SM, Mun Y, Lee K, Seong C. Augmented Effects on Neovascularization by Mixing the Conditioned Medium from Early EPCs into Late EPCs Derived from Human Cord Blood. Blood. 108: 3936-3936. DOI: 10.1182/blood.v108.11.3936.3936 |
0.103 |
|
| 2008 |
Chang HJ, Lee KE, Choi MY, Lee JH, Nam EM, Mun YC, Seong CM, Lee KJ, Suh HS, Lee SN. Risk factors of radiation pneumonitis in lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 7573. PMID 27947410 DOI: 10.1200/jco.2008.26.15_suppl.7573 |
0.103 |
|
| 2018 |
Hong J, Bang SM, Mun YC, Yhim HY, Lee J, Lim HS, Oh D. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP). Journal of Korean Medical Science. 33: e142. PMID 29736158 DOI: 10.3346/jkms.2018.33.e142 |
0.103 |
|
| 2005 |
Yoo E, Ahn J, Bae Y, Lee S, Lee Sm, Mun Y, Lee K, Seong C. Characterization of ‘Early’ vs ‘Late’ Endothelial Progenitor Cells (EPCs) Which Are Derived from Human Umbilical Cord Blood (HCB) during Ex Vivo Expansion. Blood. 106: 1706-1706. DOI: 10.1182/blood.V106.11.1706.1706 |
0.102 |
|
| 2003 |
Yoo ES, Lee KE, Seo JW, Yoo EH, Lee MA, Im SA, Mun YC, Lee SN, Huh JW, Kim MJ, Jo DY, Ahn JY, Lee SM, Chung WS, Kim JH, et al. Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion Stem Cells. 21: 228-235. PMID 12634419 DOI: 10.1634/stemcells.21-2-228 |
0.101 |
|
| 2015 |
Mun YS, Lee MS, Park JS, Lee JW, Jung SY, Yoon HJ, Han HY. An unusual case of candidemia presenting as acute respiratory distress syndrome after a small bowel bezoar removal operation. Annals of Surgical Treatment and Research. 88: 48-51. PMID 25553325 DOI: 10.4174/astr.2015.88.1.48 |
0.101 |
|
| 2007 |
Lee K, Jang H, Choi M, Kong J, Lee S, Kwon J, Nam E, Mun Y, Seong C, Lee S. Clinical analysis of multiple primary cancers Journal of Clinical Oncology. 25: 19639-19639. DOI: 10.1200/jco.2007.25.18_suppl.19639 |
0.099 |
|
| 2017 |
Jang JH, Kim JY, Mun YC, Bang SM, Lim YJ, Shin DY, Choi YB, Yhim HY, Lee JW, Kook H. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Research. 52: 254-263. PMID 29333401 DOI: 10.5045/br.2017.52.4.254 |
0.099 |
|
| 2017 |
Park G, Jeong HW, Lee J, Mun YC, Sung SH, Han SJ. Lymphedema Associated With Primary Amyloidosis: A Case Study. Annals of Rehabilitation Medicine. 41: 887-891. PMID 29201830 DOI: 10.5535/arm.2017.41.5.887 |
0.098 |
|
| 2005 |
Nam S, Kwon JM, Mun Y, Lee K, Lee SY, Chung W, Lee SN, Seong C. A Case of Coexistent Chronic Lymphocytic Leukemia and Multiple Myeloma The Korean Journal of Hematology. 40: 41. DOI: 10.5045/kjh.2005.40.1.41 |
0.098 |
|
| 2012 |
Hahm C, Mun YC, Seong CM, Chung WS, Huh J. Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality. Annals of Laboratory Medicine. 32: 445-9. PMID 23130347 DOI: 10.3343/alm.2012.32.6.445 |
0.095 |
|
| 2005 |
Chung JW, Kim GY, Mun YC, Ahn JY, Seong CM, Kim JH. Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells. Experimental & Molecular Medicine. 37: 45-50. PMID 15761251 DOI: 10.1038/emm.2005.6 |
0.095 |
|
| 2007 |
Mun Y, Oh SA, Lee K, Yoo E, Chang H, Choi M, Ahn J, Kim J, Seong C. Hematopoietic Stem Cells Mobilization by G-CSF and LTB4 Was Significantly Suppressed by an Oxygen Radical Scavenger or an Inhibitor of NADPH Oxidase. Blood. 110: 4911-4911. DOI: 10.1182/blood.v110.11.4911.4911 |
0.095 |
|
| 2015 |
Lim E, Jo C, Kim H, Kim MH, Mun Y, Chun J, Ye Y, Hwang J, Ha KS, Roh KC, Kang K, Yoon S, Lee J. Facile Synthesis of Nb2O5@Carbon Core-Shell Nanocrystals with Controlled Crystalline Structure for High-Power Anodes in Hybrid Supercapacitors. Acs Nano. PMID 26095456 DOI: 10.1021/Acsnano.5B02601 |
0.093 |
|
| 2014 |
Bang SM, Jang MJ, Kim KH, Yhim HY, Kim YK, Nam SH, Hwang HG, Bae SH, Kim SH, Mun YC, Kim YK, Kim I, Choi WI, Jung CW, Park NH, et al. Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. Journal of Korean Medical Science. 29: 164-71. PMID 24550640 DOI: 10.3346/jkms.2014.29.2.164 |
0.093 |
|
| 2005 |
Mun Y, Lee S, Lee K, Yoo E, Kang ES, Lee Sm, Ahn J, Bae Y, Kim G, Lee SN, Chung W, Kim MK, Hyun MS, Kim J, Seong C. Potential Usefulness of Leukotriene B4 (LTB4) on Mobilization of Hematopoietic Progenitor Cells (HPC). Blood. 106: 5271-5271. DOI: 10.1182/blood.V106.11.5271.5271 |
0.091 |
|
| 2015 |
Lee J, Yoo JM, Ye Y, Mun Y, Lee S, Kim OH, Rhee HW, Lee HI, Sung YE. Development of highly stable and mass transfer-enhanced cathode catalysts: Support-free electrospun intermetallic FePt nanotubes for polymer electrolyte membrane fuel cells Advanced Energy Materials. 5. DOI: 10.1002/Aenm.201402093 |
0.089 |
|
| 2004 |
Mun Y, Lee K, Kwon JM, Nam S, Yoo ES, Bae Y, Lee S, Ahn J, Hyun MS, Kwon KY, Lee SN, Seong C. Establishment of Effective B Lymphocyte Ex Vivo Expansion on Human Cord Blood Using TPO, SCF, FL, IL-4, IL-10, and CD40L. Blood. 104: 2882-2882. DOI: 10.1182/blood.v104.11.2882.2882 |
0.088 |
|
| 2019 |
Lee MJ, Jung HK, Lee KE, Mun YC, Park S. Degranulated Eosinophils Contain More Fine Nerve Fibers in the Duodenal Mucosa of Patients With Functional Dyspepsia. Journal of Neurogastroenterology and Motility. PMID 30827070 DOI: 10.5056/jnm18176 |
0.087 |
|
| 2016 |
Nishida T, Yoshidome H, Shinmura K, Mun Y, Satou Y, Sasaki S, Oki A, Kato K, Nakamura J, Miyazaki M. A rare resected leiomyosarcoma of the portal vein origin with well-developed collateral veins Japanese Journal of Gastroenterological Surgery. 49: 819-826. DOI: 10.5833/jjgs.2015.0153 |
0.085 |
|
| 2014 |
Choi BS, Mun YC, Kim JY, Lee YH. Transplant physicians' perceptions of cord blood transplantation in Korea: a questionnaire survey. Blood Research. 49: 228-33. PMID 25548755 DOI: 10.5045/br.2014.49.4.228 |
0.084 |
|
| 2010 |
Yoo E, Mun Y, Nam EM, Lee KE, Huh JW, Lee SN, Cho JY, Ahn JY, Lee S, Seong C. Nox2 siRNA Transfection Down Regulates VEGF Induced-Angiogenesis on Endothelial Progenitor Cells Which Are Derived From HCB Blood. 116: 5188-5188. DOI: 10.1182/blood.V116.21.5188.5188 |
0.083 |
|
| 2014 |
Cho IJ, Mun YC, Kwon KH, Shin GJ. Effect of anemia correction on left ventricular structure and filling pressure in anemic patients without overt heart disease. The Korean Journal of Internal Medicine. 29: 445-53. PMID 25045292 DOI: 10.3904/kjim.2014.29.4.445 |
0.083 |
|
| 2008 |
Choi MY, Lee KE, Chang HJ, Sung SH, Moon BI, Choi HY, Suh HS, Nam EM, Mun YC, Seong CM, Lee SN. Prognostic significance of triple-negative phenotype in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 11587. PMID 27950309 DOI: 10.1200/jco.2008.26.15_suppl.11587 |
0.083 |
|
| 2015 |
Mun YS, Cho BS, Jang JH, Lee MS, Kwon OS. Femoropopliteal Bypass with Varicose Greater Saphenous Vein International Journal of Angiology. DOI: 10.1055/s-0035-1546438 |
0.082 |
|
| 2017 |
So M, Park S, Mun YC, Seong C, Huh HJ, Huh J. Neutrophilic Leukemoid Reaction Associated with Malignancy Initially Suspected as Chronic Neutrophilic Leukemia Laboratory Medicine Online. 7: 206. DOI: 10.3343/LMO.2017.7.4.206 |
0.082 |
|
| 2018 |
Park S, Mun YC, Seong C, Huh HJ, Huh J. Variable Natural Killer Cell Activity in Hematological Malignancies at Diagnosis Laboratory Medicine Online. 8: 41. DOI: 10.3343/LMO.2018.8.2.41 |
0.081 |
|
| 2010 |
Mun Y, Ahn JY, Lee S, Yoo E, Cho JY, Lee KE, Nam EM, Lee SN, Seong C. Elevation of Plasma Leukotriene B4 on G-CSF-Induced Hematopoietic Stem Cells Mobilization In Normal Individuals Blood. 116: 4437-4437. DOI: 10.1182/blood.v116.21.4437.4437 |
0.08 |
|
| 2012 |
Kim DS, Jeon BK, Lee YE, Woo WH, Mun YJ. Diosgenin Induces Apoptosis in HepG2 Cells through Generation of Reactive Oxygen Species and Mitochondrial Pathway. Evidence-Based Complementary and Alternative Medicine : Ecam. 2012: 981675. PMID 22719792 DOI: 10.1155/2012/981675 |
0.08 |
|
| 2014 |
Jeon BK, Kang MK, Lee GT, Lee KK, Lee HS, Woo WH, Mun YJ. EPA attenuates ultraviolet radiation-induced downregulation of aquaporin-3 in human keratinocytes. Archives of Pharmacal Research. PMID 25269537 DOI: 10.1007/s12272-014-0482-6 |
0.079 |
|
| 2002 |
Mun YC, Park HJ, Shin KC, Chung JH, Lee KH. The Influence of Fat-Free Mass to Maximum Exercise Performance in Patients with Chronic Obstructive Pulmonary Disease Tuberculosis and Respiratory Diseases. 52: 346. DOI: 10.4046/trd.2002.52.4.346 |
0.079 |
|
| 2003 |
Woo CH, Yoo MH, You HJ, Cho SH, Mun YC, Seong CM, Kim JH. Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. Journal of Immunology (Baltimore, Md. : 1950). 170: 6273-9. PMID 12794160 DOI: 10.4049/JIMMUNOL.170.12.6273 |
0.078 |
|
| 2001 |
Mun YC, Yu SK, Park HJ, Park JW, Shin KC, Chung JH, Lee KH, Kim JS. The Differences in Resting Pulmonary Function in Relation to the Nutritional status of Patients with Chronic Obstructive Pulmonary Disease Tuberculosis and Respiratory Diseases. 51: 570. DOI: 10.4046/trd.2001.51.6.570 |
0.078 |
|
| 2013 |
Yoo E, Mun Y, Ahn J, Huh J, Seong CM. Restoration of redox enzymes is correlated with reduction of BCR-ABL protein in philadelphia positive cells during imatinib therapy Experimental Hematology. 41: S58. DOI: 10.1016/j.exphem.2013.05.226 |
0.077 |
|
| 2006 |
Mun Y, Lee S, Lee K, Yoo E, Lee SM, Kong JH, Ahn J, Bae Y, Lee S, Kim J, Seong C. The LTB4 Receptor Is Involved Not Only in the Downstream Pathway of rh-GCSF Mobilization but in the LTB4 Mobilization Pathway in C57BL/6 Mice. Blood. 108: 5216-5216. DOI: 10.1182/blood.v108.11.5216.5216 |
0.076 |
|
| 2005 |
Patton J, Sullivan T, Mun Y, Wallace J. Effectiveness of darbepoetin alfa 200 mcg every 2 weeks (Q2W) for the treatment of anemia in myelodysplastic syndrome (MDS) Journal of Clinical Oncology. 23: 6125-6125. DOI: 10.1200/jco.2005.23.16_suppl.6125 |
0.075 |
|
| 2013 |
Jun HJ, Kim K, Kim SJ, Mun YC, Bang SM, Won JH, Kim CS, Lee JH. Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: results of multicenter analysis. American Journal of Hematology. 88: 52-5. PMID 23027340 DOI: 10.1002/ajh.23333 |
0.075 |
|
| 2008 |
Mun Y, Oh SA, Lee K, Yoo E, Choi MY, Ahn J, Seong C. Effects of Transmigration of Bone Marrow Nuclear Cells Through Endothelial Cell and Stromal Cell by Leukotriene B4and Inhibition of Reactive Oxygen Species The Ewha Medical Journal. 31: 65. DOI: 10.12771/EMJ.2008.31.2.65 |
0.074 |
|
| 2014 |
Koh EH, Cho YW, Mun YJ, Ryu JH, Kim EJ, Choi DS, Maeng KY, Han J, Kang D. Upregulation of human mammaglobin reduces migration and invasion of breast cancer cells. Cancer Investigation. 32: 22-9. PMID 24328556 DOI: 10.3109/07357907.2013.861473 |
0.073 |
|
| 2013 |
Mun Y, Jo C, Hyeon T, Lee J, Ha KS, Jun KW, Lee SH, Hong SW, Lee HI, Yoon S. Simple synthesis of hierarchically structured partially graphitized carbon by emulsion/block-copolymer co-template method for high power supercapacitors Carbon. 64: 391-402. DOI: 10.1016/J.Carbon.2013.07.092 |
0.073 |
|
| 2012 |
Huh J, Mun YC, Chung WS, Seong CM. Ring chromosome 5 in acute myeloid leukemia defined by whole-genome single nucleotide polymorphism array. Annals of Laboratory Medicine. 32: 307-11. PMID 22779075 DOI: 10.3343/alm.2012.32.4.307 |
0.072 |
|
| 2012 |
Mun Y, Mun I. Privatizing the social security program in the U.S.: How to overcome the transition costs International Review of Public Administration. 17: 39-62. |
0.071 |
|
| 2014 |
Athirajan V, Razak IA, Thurairajah N, Ghani WM, Ching HN, Yang YH, Peng KN, Abdul Rahman ZA, Mustafa WM, Abraham MT, Kiong TK, Mun YK, Jalil N, Zain RB. High serum level of retinol and α-tocopherol affords protection against oral cancer in a multiethnic population. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 8183-9. PMID 25339003 DOI: 10.7314/APJCP.2014.15.19.8183 |
0.07 |
|
| 2014 |
Won HS, Lee KE, Sung SH, Choi MY, Jo JY, Nam EM, Mun YC, Seong CM, Lee SN. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer. Tumori. 100: 80-6. PMID 24675496 DOI: 10.1700/1430.15820 |
0.068 |
|
| 2015 |
Lee S, Choun M, Ye Y, Lee J, Mun Y, Kang E, Hwang J, Lee YH, Shin CH, Moon SH, Kim SK, Lee E, Lee J. Designing Highly Active Metal-Free Oxygen Reduction Catalyst in Membrane Electrode Assemblies for Alkaline Fuel Cells: Effects of Pore Size and Doping-Site Position. Angewandte Chemie (International Ed. in English). PMID 26087961 DOI: 10.1002/Anie.201501590 |
0.067 |
|
| 2005 |
Mun Y, Ahn J, Lee K, Yoo E, Lee Sm, Bae Y, Lee S, Kim MK, Hyun MS, Seong C. Hyaluronic Acid Enhances To Differentiate into Myelo-Megakaryocytic Lineages during Ex-Vivo Expansion of Human Cord Blood(HCB) Using TPO, SCF and FL. Blood. 106: 5270-5270. DOI: 10.1182/blood.v106.11.5270.5270 |
0.066 |
|
| 2016 |
Kim HC, Min TB, Mun YB, Kim JY, Choi HK, Lee HS. Effect of high early strength cement and accelerator concentrations on the low-temperature compressive strength of concrete Journal of Ceramic Processing Research. 17: 641-647. |
0.066 |
|
| 2010 |
Jo J, Nam E, Lee K, Mun Y, Seong C, Lee S, Min S, Lee H, Cho M. Prognostic significance of S100A4 expression in biliary tract cancers. Journal of Clinical Oncology. 28: e14620-e14620. DOI: 10.1200/jco.2010.28.15_suppl.e14620 |
0.065 |
|
| 2014 |
Sohn MJ, Mun YC, Seong CM, Chung WS, Huh J. Chromothripsis Identified by Copy Number Profiling in a Case of Plasma Cell Leukaemia Journal of Laboratory Medicine and Quality Assurance. 36: 107-112. DOI: 10.15263/jlmqa.2014.36.2.107 |
0.065 |
|
| 2014 |
Yang N, Chung WS, Mun YC, Huh J. Systemic Epstein-Barr Virus-Positive T-cell Lymphoproliferative Disease of Childhood Presenting as Hemophagocytic Lymphohistiocytosis with Chromosomal Abnormalities Journal of Laboratory Medicine and Quality Assurance. 36: 210-215. DOI: 10.15263/jlmqa.2014.36.4.210 |
0.064 |
|
| 2016 |
Mun Y, Shim J, Kim K, Han JW, Kim SK, Ye Y, Hwang J, Lee S, Jang J, Kim YT, Lee J. Direct access to aggregation-free and small intermetallic nanoparticles in ordered, large-pore mesoporous carbon for an electrocatalyst Rsc Advances. 6: 88255-88264. DOI: 10.1039/C6Ra14861A |
0.063 |
|
| 2013 |
Oh SJ, Park TS, Lee JY, Mun YC, Seong CM, Marschalek R, Meyer C, Chung WS, Huh J. Acute promyelocytic leukemia with a rare PML exon 4/ RARA exon 3 fusion transcript variant. Acta Haematologica. 130: 176-80. PMID 23751413 DOI: 10.1159/000348551 |
0.062 |
|
| 2017 |
Huh J, Yang N, Park S, Mun Y, Seong C, Huh HJ. Characteristics of Chromosome 17p Aberrations Identified by Metaphase Cytogenetics, Interphase FISH and Sequencing in Multiple Myeloma Clinical Lymphoma Myeloma and Leukemia. 17: e37. DOI: 10.1016/j.clml.2017.03.064 |
0.061 |
|
| 2012 |
Huh J, Mun YC, Seong CM, Chung WS. ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion. Annals of Hematology. 91: 1813-5. PMID 22453304 DOI: 10.1007/s00277-012-1450-1 |
0.058 |
|
| 2013 |
Ko H, Park S, Mun Y, Lee C. Effects of Pt capping and annealing on the photoluminescence properties of ZnO nanorods Materials Letters. 106: 67-70. DOI: 10.1016/j.matlet.2013.04.106 |
0.057 |
|
| 2013 |
Mun Y, Park S, An S, Lee C, Kim HW. NO2 gas sensing properties of Au-functionalized porous ZnO nanosheets enhanced by UV irradiation Ceramics International. 39: 8615-8622. DOI: 10.1016/j.ceramint.2013.04.035 |
0.056 |
|
| 2014 |
Park S, An S, Mun Y, Lee C. UV-enhanced room-temperature gas sensing of ZnGa2O4 nanowires functionalized with Au catalyst nanoparticles Applied Physics a: Materials Science and Processing. 114: 903-910. DOI: 10.1007/s00339-013-7745-9 |
0.056 |
|
| 2014 |
Park S, Mun Y, An S, In Lee W, Lee C. Enhanced photoluminescence of Au-functionalized ZnO nanorods annealed in a hydrogen atmosphere Journal of Luminescence. 147: 5-8. DOI: 10.1016/j.jlumin.2013.10.044 |
0.055 |
|
| 2014 |
Hahm C, Han SH, Mun YC, Seong CM, Chung WS, Huh J. ETV6/RUNX1 rearrangement identified by RT-PCR without evidence on FISH. Acta Haematologica. 132: 122-4. PMID 24557455 DOI: 10.1159/000356778 |
0.055 |
|
| 2014 |
Ahn HY, Cho BS, Mun YS, Jang JH, Kim CN, Lee MS, Kang YJ. Treatment results for spontaneous isolated superior mesenteric artery dissection according to our previous guidelines and collective literature review. Annals of Vascular Surgery. 28: 1595-601. PMID 24858595 DOI: 10.1016/j.avsg.2014.04.007 |
0.055 |
|
| 2013 |
An S, Park S, Mun Y, Lee C. Uv enhanced no2 sensing properties of pt functionalized Ga 2O3 nanorods Bulletin of the Korean Chemical Society. 34: 1632-1636. DOI: 10.5012/bkcs.2013.34.6.1632 |
0.054 |
|
| 2013 |
Park S, An S, Mun Y, Lee C. UV-enhanced NO2 gas sensing properties of SnO2-core/ZnO-shell nanowires at room temperature. Acs Applied Materials & Interfaces. 5: 4285-92. PMID 23627276 DOI: 10.1021/am400500a |
0.052 |
|
| 2000 |
Park HJ, Mun YC, Yu SK, Shin KC, Chung JH, Lee KH, Kim MJ, Lee JC. A Case of Combined Small Cell Carcinoma with Non-Small Cell Lung Carcinoma, Adenocarcinoma and Squamous Cell Carcinoma Tuberculosis and Respiratory Diseases. 48: 72. DOI: 10.4046/trd.2000.48.1.72 |
0.052 |
|
| 2013 |
Park S, An S, Mun Y, Kim HW, Lee C. Enhanced luminescence of Ag-decorated ZnO nanorods Journal of Materials Science: Materials in Electronics. 24: 4906-4912. DOI: 10.1007/s10854-013-1496-4 |
0.051 |
|
| 2009 |
Kim S, Jun H, Kim K, Lee J, Bang S, Won J, Mun Y, Lee M. A449 Clinical Features and Treatment Outcomes of AL Amyloidosis in Korea Clinical Lymphoma and Myeloma. 9: S72. DOI: 10.1016/S1557-9190(11)70588-1 |
0.051 |
|
| 2013 |
Lee YH, Kim JY, Mun YC, Koo HH. A proposal for improvement in the utilization rate of banked cord blood. Blood Research. 48: 5-7. PMID 23589786 DOI: 10.5045/br.2013.48.1.5 |
0.048 |
|
| 2013 |
Mun Y, Lee K. Network-controlled cross-layer fast handover for MIPv6 over IEEE 802.16m networks Simulation Series. 45: 142-147. |
0.046 |
|
| 2016 |
Park S, Mun Y. Prediction method about power consumption by using utilization rate of resource in cloud computing environment 2016 International Conference On Big Data and Smart Computing, Bigcomp 2016. 265-268. DOI: 10.1109/BIGCOMP.2016.7425924 |
0.045 |
|
| 2007 |
Shea T, Kewalramani T, Mun Y, Jayne J, Dreiling L. 217: Evaluation of single-dose palifermin to reduce mucositis Biology of Blood and Marrow Transplantation. 13: 79-80. DOI: 10.1016/J.BBMT.2006.12.221 |
0.043 |
|
| 2012 |
Yeon J, Lee JH, Lee HS, Song H, Mun YK, Choi YS, Choi HY, Lee S, Yoon JB. An effective light-extracting microstructure for a single-sheet backlight unit for liquid crystal display Journal of Micromechanics and Microengineering. 22. DOI: 10.1088/0960-1317/22/9/095006 |
0.042 |
|
| 2013 |
Park S, Ko H, Mun Y, Lee C. Photoluminescence in MgO-ZnO nanorods enhanced by hydrogen plasma treatment Bulletin of the Korean Chemical Society. 34: 3367-3371. DOI: 10.5012/bkcs.2013.34.11.3367 |
0.042 |
|
| 2016 |
Jo HJ, Mun YH, Kim JS, Lee SJ. Dependence on the incident light power of the internal electric fields in a GaAs p-i-n solar cell according to bright photoreflectance spectroscopy Journal of the Korean Physical Society. 69: 80-84. DOI: 10.3938/jkps.69.80 |
0.041 |
|
| 2000 |
Shin KC, Ryoo HM, Park HJ, Mun YC, Chung JH, Lee KH. Relative Risk for Lung Cancer According to Smoking Habits in Korean Tuberculosis and Respiratory Diseases. 48: 331. DOI: 10.4046/trd.2000.48.3.331 |
0.041 |
|
| 2013 |
Mun Y, Park S, Ko H, Lee C, Lee S. NO2 gas sensing properties of ZnO/ZnS core-shell nanowires Journal of the Korean Physical Society. 63: 1595-1600. DOI: 10.3938/jkps.63.1595 |
0.04 |
|
| 2014 |
Park S, An S, Mun Y, Lee C. UV-activated gas sensing properties of ZnS nanorods functionalized with Pd Current Applied Physics. 14. DOI: 10.1016/j.cap.2013.11.041 |
0.039 |
|
| 2002 |
Chung JH, Mun YC, Park HJ, Shin KC, Lee KH. Effect of Neutrophil Elastase inhibitor, ICI 200,355, on Interleukin-1 Induced acute lung injury in rats Yeungnam University Journal of Medicine. 19: 55. DOI: 10.12701/yujm.2002.19.1.55 |
0.038 |
|
| 2014 |
Yhim HY, Jang MJ, Bang SM, Kim KH, Kim YK, Nam SH, Bae SH, Kim SH, Mun YC, Kim I, Jung CW, Oh D. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. Journal of Thrombosis and Haemostasis : Jth. 12: 1035-43. PMID 24837640 DOI: 10.1111/jth.12611 |
0.037 |
|
| 2012 |
Hahm C, Hwang Y, Mun YC, Seong CM, Chung WS, Huh J. Sole Trisomy 22 Not Associated with inv(16) in Myelodysplastic Syndrome The Ewha Medical Journal. 35: 62. DOI: 10.12771/EMJ.2012.35.1.62 |
0.034 |
|
| 2016 |
Park Y, Kim H, Mun Y, Ko Y, Cho DI, Ko H. Low-power and low-noise capacitive sensing IC using opamp sharing technique Ieee Sensors Journal. DOI: 10.1109/JSEN.2016.2606510 |
0.034 |
|
| 2015 |
Won HS, Lee KE, Lee KM, Nam EM, Mun YC, Seong C, Lee S. Manipulation of β-catenin pathway to overcome endocrine resistance in breast cancer. Journal of Clinical Oncology. 33: e11530-e11530. DOI: 10.1200/jco.2015.33.15_suppl.e11530 |
0.03 |
|
| 2014 |
Ham EM, Cho BS, Ye JB, Mun YS, Choi YJ, Kwon OS. The endovascular treatment of a ruptured aneurysm of the middle colic artery combined with an isolated dissection of superior mesenteric artery: report of a case. Vascular and Endovascular Surgery. 48: 352-5. PMID 24407510 DOI: 10.1177/1538574413518615 |
0.028 |
|
| 2001 |
Mun YC, Yu SK, Park HJ, Shin KC, Chung JH, Lee KH, Lee JC. The Differences of the Smoking Habit Between Emphysema and Chronic Bronchitis Tuberculosis and Respiratory Diseases. 50: 693. DOI: 10.4046/trd.2001.50.6.693 |
0.026 |
|
| 2013 |
Hartono YD, Mun YY, Zhang D. Adsorption and folding dynamics of MPER of HIV-1 gp41 in the presence of DPC micelle. Proteins. 81: 933-44. PMID 23345046 DOI: 10.1002/prot.24256 |
0.026 |
|
| 2012 |
Chou HS, Truitt KE, Moberly JB, Merante D, Choi Y, Mun Y, Pfützner A. A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus. Diabetes, Obesity & Metabolism. 14: 1000-9. PMID 22686944 DOI: 10.1111/j.1463-1326.2012.01631.x |
0.025 |
|
| 2016 |
Park S, Chung H, Seo EK, Mun YC, Lee M. Two Cases of Medical Device-RelatedCorynebacterium striatumInfection: A Meningitis and A Sepsis Annals of Clinical Microbiology. 19: 28. DOI: 10.5145/ACM.2016.19.1.28 |
0.021 |
|
| 2015 |
Lim T, Woo S, Mun YG, Yim E, Koh JH, Park KS. Polymyalgia rheumatica following paraspinal muscle inflammation and sacroiliitis. The Korean Journal of Internal Medicine. 30: 415-7. PMID 25995675 DOI: 10.3904/kjim.2015.30.3.415 |
0.019 |
|
| 2014 |
Kim K, Clariana RB, Mun Y. Using pathfinder network as a measure of lexical structure of bilingual learners Proceedings - Ieee 14th International Conference On Advanced Learning Technologies, Icalt 2014. 355-359. DOI: 10.1109/ICALT.2014.106 |
0.019 |
|
| 2013 |
Tang MC, Chin MWS, Lim KM, Mun YS, Ng RTL, Tay DHS, Ng DKS. Systematic approach for conceptual design of an integrated biorefinery with uncertainties Clean Technologies and Environmental Policy. 15: 783-799. DOI: 10.1007/s10098-013-0582-x |
0.014 |
|
| Hide low-probability matches. |